The FSUE Moscow Endocrine Plant received an international certificate of conformity to GMP of the European Union, issued by the State Agency of Medicines of the Republic of Latvia
No. ZVA/LV/2019/002H from 04.02.2019 for the line of the production of sterile drugs.
The pharmaceutical quality system of the Enterprise provides the compliance with international and regional regulations and guarantees the safety, quality and effectiveness of our products, helps to maintain the proper level of control of products and processes. This, in turn, allows our consumers to receive quality drugs and get benefit of them.
We value the quality of our products and work for people, for the good of their health.
Comment type is not specified in the component properties.